CIBC Private Wealth Group LLC Purchases 120 Shares of HCA Healthcare, Inc. (NYSE:HCA)

CIBC Private Wealth Group LLC raised its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.6% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 20,059 shares of the company’s stock after purchasing an additional 120 shares during the period. CIBC Private Wealth Group LLC’s holdings in HCA Healthcare were worth $6,243,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of HCA. Whipplewood Advisors LLC bought a new stake in HCA Healthcare during the 4th quarter valued at $31,000. Tidemark LLC purchased a new position in HCA Healthcare in the fourth quarter valued at about $36,000. Legacy Investment Solutions LLC bought a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $39,000. Activest Wealth Management raised its stake in shares of HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after acquiring an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. grew its holdings in HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after purchasing an additional 50 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

Insider Activity at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares in the company, valued at $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of analysts have recently weighed in on the company. Bank of America lowered their price objective on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, January 27th. Barclays cut their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a report on Monday, January 27th. Royal Bank of Canada cut their price target on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research note on Monday, January 27th. Truist Financial dropped their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Finally, Morgan Stanley dropped their price target on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $345.86 on Wednesday. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The business has a 50-day moving average price of $325.79 and a 200 day moving average price of $340.25. The firm has a market cap of $85.15 billion, a PE ratio of 15.74, a P/E/G ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period last year, the firm posted $5.90 earnings per share. Sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.83%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date was Monday, March 17th. HCA Healthcare’s dividend payout ratio is 13.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.